270 related articles for article (PubMed ID: 19012672)
21. The additional therapeutic effect of group music therapy for schizophrenic patients: a randomized study.
Ulrich G; Houtmans T; Gold C
Acta Psychiatr Scand; 2007 Nov; 116(5):362-70. PubMed ID: 17919155
[TBL] [Abstract][Full Text] [Related]
22. Individual quality of life of people with severe mental disorders.
Pitkänen A; Hätönen H; Kuosmanen L; Välimäki M
J Psychiatr Ment Health Nurs; 2009 Feb; 16(1):3-9. PubMed ID: 19192080
[TBL] [Abstract][Full Text] [Related]
23. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
Karow A; Schäfer I; Hirdes F; Osterwald C; Naber D
Psychiatr Prax; 2008 Sep; 35(6):286-93. PubMed ID: 18504688
[TBL] [Abstract][Full Text] [Related]
24. Effects of exercise on mental and physical health parameters of persons with schizophrenia.
Beebe LH; Tian L; Morris N; Goodwin A; Allen SS; Kuldau J
Issues Ment Health Nurs; 2005 Jul; 26(6):661-76. PubMed ID: 16020076
[TBL] [Abstract][Full Text] [Related]
25. Assessment of quality of life with the WHOQOL-BREF in a group of Turkish psychiatric patients compared with diabetic and healthy subjects.
Akvardar Y; Akdede BB; Ozerdem A; Eser E; Topkaya S; Alptekin K
Psychiatry Clin Neurosci; 2006 Dec; 60(6):693-9. PubMed ID: 17109703
[TBL] [Abstract][Full Text] [Related]
26. Premorbid adjustment in schizophrenia and schizoaffective disorder.
Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A
Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333
[TBL] [Abstract][Full Text] [Related]
27. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
[TBL] [Abstract][Full Text] [Related]
28. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
[TBL] [Abstract][Full Text] [Related]
29. Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers.
Mackell JA; Harrison DJ; McDonnell DD
Ment Health Serv Res; 2005 Dec; 7(4):225-8. PubMed ID: 16320105
[TBL] [Abstract][Full Text] [Related]
30. Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients.
Shiloh R; Schapir L; Bar-Ziv D; Stryjer R; Konas S; Louis R; Hermesh H; Munitz H; Weizman A; Valevski A
Eur Neuropsychopharmacol; 2009 Sep; 19(9):654-8. PubMed ID: 19493658
[TBL] [Abstract][Full Text] [Related]
31. [Religiousness of patients with diagnosis of schizophrenia. Introductory studies].
Tomczak P
Psychiatr Pol; 2005; 39(5):869-81. PubMed ID: 16358588
[TBL] [Abstract][Full Text] [Related]
32. Quality of life of patients with schizophrenia 2.
Daradkeh TK; Al Habeeb T
East Mediterr Health J; 2005; 11(5-6):898-904. PubMed ID: 16761659
[TBL] [Abstract][Full Text] [Related]
33. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
34. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
[TBL] [Abstract][Full Text] [Related]
35. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
[TBL] [Abstract][Full Text] [Related]
36. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
Favrod J; Ernst F; Giuliani F; Bonsack C
Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
[TBL] [Abstract][Full Text] [Related]
37. Sexual problems in a sample of the Turkish psychiatric population.
Hariri AG; Karadag F; Gurol DT; Aksoy UM; Tezcan AE
Compr Psychiatry; 2009; 50(4):353-60. PubMed ID: 19486734
[TBL] [Abstract][Full Text] [Related]
38. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
39. A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study.
Dodd KJ; Duffy S; Stewart JA; Impey J; Taylor N
Disabil Rehabil; 2011; 33(13-14):1222-9. PubMed ID: 20950141
[TBL] [Abstract][Full Text] [Related]
40. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
